Close Menu

NEW YORK (360Dx) – A team led by researchers from France’s Sys2diag laboratory have developed synthetic biology-based biosensors capable of detecting biomarkers in human clinical samples.

The sensors consist of synthetic protein signaling networks encased in phospholipid bilayer membranes. In a proof-of-concept study published last month in Molecular Systems Biology, the networks were able to detect diabetes-linked markers in patient urine samples.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.